生物技术通讯
生物技術通訊
생물기술통신
LETTERS IN BIOTECHNOLOGY
2014年
1期
97-99
,共3页
柳丽娟%谢玉玲%戴振贤%卓传尚%吴玉水
柳麗娟%謝玉玲%戴振賢%卓傳尚%吳玉水
류려연%사옥령%대진현%탁전상%오옥수
丙型肝炎病毒%丙型肝炎病毒抗体%化学发光法%ELISA
丙型肝炎病毒%丙型肝炎病毒抗體%化學髮光法%ELISA
병형간염병독%병형간염병독항체%화학발광법%ELISA
hepatitis C virus%hepatitis C virus antibody%chemiluminescence immunoassay%ELISA
目的:建立丙型肝炎病毒(HCV)抗体化学发光免疫检测方法,并分析其临床应用价值。方法:应用基因工程重组的HCV抗原包被微孔板,以辣根过氧化物酶标记的羊抗人IgG为二抗,并结合鲁米诺化学发光底物系统,建立HCV抗体化学发光免疫检测方法;应用HCV抗体诊断试剂国家参考品分析所建立方法的特异性、灵敏度、稳定性和精密性,并与北京万泰公司的ELISA试剂盒同时检测临床血清样本350份,比较检测结果。结果:检测结果符合国家参考品质量标准。批内变异系数5.1%~6.6%,批间变异系数9.5%;试剂盒置37℃考核3 d,其稳定性良好;与万泰公司的ELISA检测结果对照,阳性符合率分别为99.0%,阴性符合率分别为100%,总符合率为99.4%;Kappa值为0.986,一致性强度最强。结论:建立了特异、敏感和稳定的HCV抗体化学发光免疫检测方法,适用于HCV感染的批量筛查,具有较大的临床应用价值。
目的:建立丙型肝炎病毒(HCV)抗體化學髮光免疫檢測方法,併分析其臨床應用價值。方法:應用基因工程重組的HCV抗原包被微孔闆,以辣根過氧化物酶標記的羊抗人IgG為二抗,併結閤魯米諾化學髮光底物繫統,建立HCV抗體化學髮光免疫檢測方法;應用HCV抗體診斷試劑國傢參攷品分析所建立方法的特異性、靈敏度、穩定性和精密性,併與北京萬泰公司的ELISA試劑盒同時檢測臨床血清樣本350份,比較檢測結果。結果:檢測結果符閤國傢參攷品質量標準。批內變異繫數5.1%~6.6%,批間變異繫數9.5%;試劑盒置37℃攷覈3 d,其穩定性良好;與萬泰公司的ELISA檢測結果對照,暘性符閤率分彆為99.0%,陰性符閤率分彆為100%,總符閤率為99.4%;Kappa值為0.986,一緻性彊度最彊。結論:建立瞭特異、敏感和穩定的HCV抗體化學髮光免疫檢測方法,適用于HCV感染的批量篩查,具有較大的臨床應用價值。
목적:건립병형간염병독(HCV)항체화학발광면역검측방법,병분석기림상응용개치。방법:응용기인공정중조적HCV항원포피미공판,이랄근과양화물매표기적양항인IgG위이항,병결합로미낙화학발광저물계통,건립HCV항체화학발광면역검측방법;응용HCV항체진단시제국가삼고품분석소건립방법적특이성、령민도、은정성화정밀성,병여북경만태공사적ELISA시제합동시검측림상혈청양본350빈,비교검측결과。결과:검측결과부합국가삼고품질량표준。비내변이계수5.1%~6.6%,비간변이계수9.5%;시제합치37℃고핵3 d,기은정성량호;여만태공사적ELISA검측결과대조,양성부합솔분별위99.0%,음성부합솔분별위100%,총부합솔위99.4%;Kappa치위0.986,일치성강도최강。결론:건립료특이、민감화은정적HCV항체화학발광면역검측방법,괄용우HCV감염적비량사사,구유교대적림상응용개치。
Objective: To establish chemiluminescence immunoassay(CLIA) for hepatitis C virus(HCV) antibody and evaluate its clinical application value. Methods: Genetic engineered HCV antigen coated on micro-plate, and horse radish peroxidase conjugated goat-anti-human IgG as secondary, combined with luminal chemiluminescence substrate, a CLIA for HCV antibody was established. National reference substances for diagnostics of HCV anti-body were used for evaluation of specificity, sensitivity, stability and curacy of the CLIA. A sum of 350 clinical samples was detected by the established CLIA and an ELISA kit produced by the Wantai Company, Beijing. Re-sults: The CLIA detection results met the requirement of national conference substances quality criteria. The coeffi-cient of variation(CV) for within-run was 5.1%~6.6% and 9.5% for between-run assays. The CLIA kits shown good stability when kept at 37℃ for 3 days. Comparing between results determinated by using the CLIA kits and the ELISA kit, the positive coincidence rate was 99.0%, and negative coincidence rate 100%, total accuracy rate 99.4%, and Kappa value 0.986(highest-level consistency strength). Conclusion: We have successfully established specific, sensitive and stable CLIA kit for HCV antibody, which showed great clinical application value in large scanning the HCV infection.